Patent · US Active

Methods and devices for drug delivery to ocular tissue using microneedle

US10905586B2 · kind B2 · utility

8Cited by
100References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 23, 2020
Grant dateFeb 2, 2021
Priority date
Expiry dateMar 23, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/0612
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.